Dr Linda Mae Richardson, PHD in Downey, CA - Psychologist

Dr Linda Mae Richardson, PHD is a Psychologist - Clinical based in Downey, California. Dr Linda Mae Richardson is licensed to practice in California (license number 16790) and her current practice location is 7285 Quill Dr, Downey, California. She can be reached at her office (for appointments etc.) via phone at (562) 940-8767.

NPI number for Dr Linda Mae Richardson is 1346311792 and her current mailing address is 2820 Kennington Dr, Glendale, California. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1346311792.

Contact Information

	Dr Linda Mae Richardson, PHD
	7285 Quill Dr, Downey, CA 90242-2001
	(562) 940-8767
	(562) 803-0637

Healthcare Provider's Profile

Full Name	Dr Linda Mae Richardson
Gender	Female
Speciality	Psychologist - Clinical
Location	7285 Quill Dr, Downey, California
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1346311792
Provider Enumeration Date: 11/09/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Dr Linda Mae Richardson such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1346311792	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
103TC0700X	Psychologist - Clinical	16790 (California)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Linda Mae Richardson is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Linda Mae Richardson, PHD 2820 Kennington Dr, Glendale, CA 91206-1846 Ph: (818) 243-4543	Dr Linda Mae Richardson, PHD 7285 Quill Dr, Downey, CA 90242-2001 Ph: (562) 940-8767

News Archive

Ellipse Technologies' MAGEC Technology for spinal deformity treatment receives CE Mark

Ellipse Technologies, Inc. announced today it has received CE Mark (Conformité Européenne) for its MAGECTM Technology for the treatment of spinal deformity. The first application for this technology is for the treatment of spinal scoliosis in young children and teenagers. The CE Mark allows the Company to market the MAGEC System in the European Union and other countries that recognize the CE Mark for commercial distribution purposes.

Scientists identify molecular switch that controls ATF2's dual functions

The National Cancer Institute (NCI) estimates that as many as one in 51 men and women will be diagnosed with melanoma-the deadliest form of skin cancer-at some point during their lifetimes. A research team led by Ze'ev Ronai, Ph.D. at Sanford-Burnham Medical Research Institute (Sanford-Burnham) is working to unravel the molecular mechanisms underlying the development and progression of this disease in hopes of improving prevention and treatment strategies

Clinical Cancer Research publishes results of Aduro's ANZ-100 and CRS-207 Phase 1 studies

Aduro BioTech, Inc. is pleased to announce the publication of two therapeutic cancer vaccine Phase 1 studies in Clinical Cancer Research. In the article, which was featured as one of the highlights of the issue, Dr. Dung Le et al. reported that intravenous administration of ANZ-100 and CRS-207 was well tolerated in subjects with advanced, treatment-refractory cancers.

Low bowel cancer survival in the UK likely to be due to differences in staging and treatment

Incomplete diagnostic investigation and failure to get the best treatment are the most likely reasons why survival for bowel cancer patients is lower in the UK than in other comparable countries, according to new research published in the journal Acta Oncologica.

KAPIDEX to be marketed as DEXILANT in the U.S.

Takeda Pharmaceuticals North America, Inc. announced today that KAPIDEX™ (dexlansoprazole) will be marketed in the United States under the new product trade name DEXILANT™ (dexlansoprazole). The product is indicated for heartburn associated with symptomatic non-erosive gastroesophageal reflux disease (GERD), the healing of erosive esophagitis (EE) and the maintenance of healed EE.

Psychologist in Downey, CA

Dr. Leanor M Johansen, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 7285 Quill Dr, Downey, CA 90242 Phone: 562-940-6077
Dr. Paul G Shuman, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 7285 Quill Dr, Downey, CA 90242 Phone: 562-940-8700 Fax: 562-803-0637
Dr. Charles Kodimer, PHD Psychologist Medicare: May Accept Medicare Assignments Practice Location: 10927 Downey Ave Ste C, Downey, CA 90241 Phone: 562-861-6180 Fax: 951-694-0553
Rosa Maria Villalpando, PSY.D Psychologist Medicare: Medicare Enrolled Practice Location: 9911 Paramount Blvd # 190, Downey, CA 90240 Phone: 213-309-5016
Dr. Paula Bina Firestone, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 11525 Brookshire Ave, Suite 401, Downey, CA 90241 Phone: 562-904-7660 Fax: 562-904-7693
Dr. Paul Matthew Ascarate, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 7285 Quill Dr, Downey, CA 90242 Phone: 562-658-0134
Dr. Jeffrey Shulze, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 7601 Imperial Hwy, Downey, CA 90242 Phone: 623-858-1865

Dr Linda Mae Richardson, PHD - Psychologist in Downey, CA